125 related articles for article (PubMed ID: 2153817)
1. Antiulcer agents. 4-substituted 2-guanidinothiazoles: reversible, competitive, and selective inhibitors of gastric H+,K(+)-ATPase.
LaMattina JL; McCarthy PA; Reiter LA; Holt WF; Yeh LA
J Med Chem; 1990 Feb; 33(2):543-52. PubMed ID: 2153817
[TBL] [Abstract][Full Text] [Related]
2. Structure-activity relationship studies of 4-substituted-2-guanidinothiazoles: reversible inhibitors of gastric (H+/K+)-ATPase.
Ojha TN; Singh P; Sharma RC
Indian J Biochem Biophys; 1993 Aug; 30(4):239-43. PubMed ID: 8276427
[TBL] [Abstract][Full Text] [Related]
3. Reversible inhibitors of the gastric (H+/K+)-ATPase. 1. 1-Aryl-4-methylpyrrolo[3,2-c]quinolines as conformationally restrained analogues of 4-(arylamino)quinolines.
Brown TH; Ife RJ; Keeling DJ; Laing SM; Leach CA; Parsons ME; Price CA; Reavill DR; Wiggall KJ
J Med Chem; 1990 Feb; 33(2):527-33. PubMed ID: 2153816
[TBL] [Abstract][Full Text] [Related]
4. Antiulcer agents. 5. Inhibition of gastric H+/K(+)-ATPase by substituted imidazo[1,2-a]pyridines and related analogues and its implication in modeling the high affinity potassium ion binding site of the gastric proton pump enzyme.
Kaminski JJ; Wallmark B; Briving C; Andersson BM
J Med Chem; 1991 Feb; 34(2):533-41. PubMed ID: 1847427
[TBL] [Abstract][Full Text] [Related]
5. Synthesis of (aryloxy)alkylamines. 1. Novel antisecretory agents with H+K+-ATPase inhibitory activity.
Sanfilippo PJ; Urbanski M; Press JB; Hajos ZG; Shriver DA; Scott CK
J Med Chem; 1988 Sep; 31(9):1778-85. PubMed ID: 2842503
[TBL] [Abstract][Full Text] [Related]
6. Studies on antiulcer drugs. VI. 4-Furyl-2-guanidinothiazoles and related compounds as potent histamine H2-receptor antagonists.
Katsura Y; Inoue Y; Tomishi T; Itoh H; Ishikawa H; Takasugi H
Chem Pharm Bull (Tokyo); 1992 Sep; 40(9):2432-41. PubMed ID: 1359931
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and antisecretory activity of 6-substituted 5-cyanomethylimidazo[2,1-b]thiazoles and 2,6-dimethyl-5-hydroxymethylimidazo[2,1-b][1,3,4]thiadiazole.
Andreani A; Leoni A; Locatelli A; Morigi R; Rambaldi M; Simon WA; Senn-Bilfinger J
Arzneimittelforschung; 2000 Jun; 50(6):550-3. PubMed ID: 10918949
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and antiulcer activity of 4-substituted 8-[(2-benzimidazolyl)sulfinylmethyl]-1,2,3,4-tetrahydroquinoli nes and related compounds.
Uchida M; Chihiro M; Morita S; Yamashita H; Yamasaki K; Kanbe T; Yabuuchi Y; Nakagawa K
Chem Pharm Bull (Tokyo); 1990 Jun; 38(6):1575-86. PubMed ID: 2170036
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of gastric H+,K(+)-ATPase by the anti-ulcer agent, sofalcone.
Murakami S; Muramatsu M; Aihara H; Otomo S
Biochem Pharmacol; 1991 Sep; 42(7):1447-51. PubMed ID: 1656986
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of H+K+ATPase by SCH 28080 and SCH 32651.
Scott CK; Sundell E
Eur J Pharmacol; 1985 Jun; 112(2):268-70. PubMed ID: 2993001
[TBL] [Abstract][Full Text] [Related]
11. Studies on proton pump inhibitors. I. Synthesis of 8-[(2-benzimidazolyl)sulfinyl]-5,6,7,8-tetrahydroquinolines and related compounds.
Uchida M; Morita S; Chihiro M; Kanbe T; Yamasaki K; Yabuuchi Y; Nakagawa K
Chem Pharm Bull (Tokyo); 1989 Jun; 37(6):1517-23. PubMed ID: 2550154
[TBL] [Abstract][Full Text] [Related]
12. SCH 28080 is a more selective inhibitor than SCH 32651 at the K+ site of gastric K+/H+-ATPase.
Beil W; Staar U; Sewing KF
Eur J Pharmacol; 1987 Jul; 139(3):349-52. PubMed ID: 2822435
[TBL] [Abstract][Full Text] [Related]
13. Superpendentic index: a novel topological descriptor for predicting biological activity.
Gupta S; Singh M; Madan AK
J Chem Inf Comput Sci; 1999; 39(2):272-7. PubMed ID: 10192943
[TBL] [Abstract][Full Text] [Related]
14. Anti-Helicobacter pylori agents. 5. 2-(Substituted guanidino)-4-arylthiazoles and aryloxazole analogues.
Katsura Y; Nishino S; Inoue Y; Sakane K; Matsumoto Y; Morinaga C; Ishikawa H; Takasugi H
J Med Chem; 2002 Jan; 45(1):143-50. PubMed ID: 11754586
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of gastric H+, K+ adenosine triphosphatase (ATPase) by substituted naphthylalkylimidazoles.
Serrato C; Waterbury D; Loury D; Smith W
Proc West Pharmacol Soc; 1989; 32():249-53. PubMed ID: 2550945
[No Abstract] [Full Text] [Related]
16. Irreversible inactivation of rat gastric (H+-K+)-ATPase in vivo by omeprazole.
Im WB; Blakeman DP; Davis JP
Biochem Biophys Res Commun; 1985 Jan; 126(1):78-82. PubMed ID: 2982382
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of the gastric (H+ + K+)-ATPase by fenoctimine.
Reenstra WW; Shortridge B; Forte JG
Biochem Pharmacol; 1985 Jul; 34(13):2331-4. PubMed ID: 2990481
[TBL] [Abstract][Full Text] [Related]
18. Studies on proton pump inhibitors. II. Synthesis and antiulcer activity of 8-[(2-benzimidazolyl)sulfinylmethyl]-1,2,3,4-tetrahydroquinolines and related compounds.
Uchida M; Chihiro M; Morita S; Kanbe T; Yamashita H; Yamasaki K; Yabuuchi Y; Nakagawa K
Chem Pharm Bull (Tokyo); 1989 Aug; 37(8):2109-16. PubMed ID: 2557164
[TBL] [Abstract][Full Text] [Related]
19. Studies on (H(+)-K+)-ATPase inhibitors of gastric acid secretion. Prodrugs of 2-[(2-pyridinylmethyl)sulfinyl]benzimidazole proton-pump inhibitors.
Sih JC; Im WB; Robert A; Graber DR; Blakeman DP
J Med Chem; 1991 Mar; 34(3):1049-62. PubMed ID: 1848293
[TBL] [Abstract][Full Text] [Related]
20. Synthesis of 4-(phenylamino)quinoline-3-carboxamides as a novel class of gastric H+/K+-ATPase inhibitors.
Uchida M; Otsubo K; Matsubara J; Ohtani T; Morita S; Yamasaki K
Chem Pharm Bull (Tokyo); 1995 Apr; 43(4):693-8. PubMed ID: 7600619
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
